NCT03608488

Brief Summary

In recent years, skeletal and nonskeletal effects of vitamin D has been studied. One of the effects of it was balance and fall prevention. However, these studies were performed on older patients who had not vitamin D deficiency. This study aimed to evaluate the effect of vitamin D replacement therapy and exercise on balance in 50-70 years-old postmenopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2018

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

August 6, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2019

Completed
8 months until next milestone

Results Posted

Study results publicly available

February 27, 2020

Completed
Last Updated

July 1, 2020

Status Verified

June 1, 2020

Enrollment Period

11 months

First QC Date

July 4, 2018

Results QC Date

September 22, 2019

Last Update Submit

June 22, 2020

Conditions

Keywords

balancevitamin Dexercisefall risk

Outcome Measures

Primary Outcomes (4)

  • Postural Stability Test (Biodex) Assessed at Baseline

    overall stability index: quantifying the ability to maintain dynamic postural stability The patient's score on this test assesses deviations from center, thus lower index means less instability and better balance. Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System. 0 is the minimum score, but there is no defined maximum score

    Baseline

  • Postural Stability Test (Biodex) Assessed After Treatment (8 Weeks)

    overall stability index: quantifying the ability to maintain dynamic postural stability. The patient's score on this test assesses deviations from center, thus a lower score is more desirable than a higher score. Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System 0 is the minimum score, but there is no defined maximum score

    After treatment (8 weeks)

  • Berg Balance Test Assessed at Baseline

    14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of \< 45 indicates individuals may be at greater risk of falling.

    Baseline

  • Berg Balance Test Assessed After Treatment (8weeks)

    14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of \< 45 indicates individuals may be at greater risk of falling.

    After treatment (8 weeks)

Secondary Outcomes (4)

  • Fall Risk Assesment Performed at Baseline

    Baseline

  • Fall Risk Assesment Performed After Treatment (8 Weeks)

    After treatment (8 weeks)

  • Health Status Assessed at Baseline

    Baseline

  • Health Status Assessed After Treatment (8 Weeks)

    After treatment (8 weeks)

Study Arms (4)

Vitamin D<10 ng/ml; Vitamin D replacement

EXPERIMENTAL

Vitamin D replacement (50.000 IU/per week, for 8 weeks)

Dietary Supplement: Vitamin D

Vitamin D<10 ng/ml; Vitamin D replacement and exercise

EXPERIMENTAL

Vitamin D replacement (50.000 IU/per week, for 8 weeks) and Core and balance exercises for 8 weeks.

Dietary Supplement: Vitamin D

Vitamin D<10 ng/ml; exercise

EXPERIMENTAL

Core and balance exercises for 8 weeks.

Other: Exercise

Vitamin D>30ng/ml; exercise

ACTIVE COMPARATOR

Core and balance exercises for 8 weeks.

Other: Exercise

Interventions

Vitamin DDIETARY_SUPPLEMENT

Vitamin D3 50.000 IU/per week, for 8 weeks

Also known as: exercise
Vitamin D<10 ng/ml; Vitamin D replacementVitamin D<10 ng/ml; Vitamin D replacement and exercise

Core stability, balance exercises

Vitamin D<10 ng/ml; exerciseVitamin D>30ng/ml; exercise

Eligibility Criteria

Age50 Years - 70 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years-old postmenopausal women
  • Vitamin D level\<10 ng/ml and Vitamin D level\>30 ng/ml
  • Independant in daily life
  • Able to do exercise
  • Able to read and write in Turkish

You may not qualify if:

  • Diabetes mellitus,
  • Polyneuropathy,
  • Spinal stenosis,
  • History of fracture or lower extremity operation,
  • Rheumatologic diseases,
  • History of chemotherapy
  • Cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sultan Abdulhamid Han Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Vitamin D DeficiencyMotor Activity

Interventions

Vitamin DExercise

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesBehavior

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic CompoundsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Tugba OZsoy-Unubol
Organization
SultanAbdulhamid

Study Officials

  • Tugba Ozsoy-Unubol, MD

    Sultan Abdulhamid Han Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2018

First Posted

August 1, 2018

Study Start

August 6, 2018

Primary Completion

July 12, 2019

Study Completion

July 12, 2019

Last Updated

July 1, 2020

Results First Posted

February 27, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations